Enzyme-Producing GE Chicken Gets Approval in the USDecember 16, 2015
The US Food and Drug Administration has approved a chicken that has been genetically engineered to produce the drug Kanuma (sebelipase alfa) in its eggs. Kanuma is a recombinant human enzyme marketed by Alexion Pharmaceuticals, meant to replace faulty enzyme in people with a rare, inherited condition that prevents the body from breaking down fatty molecules in cells.
The drug is designed to treat, lysosomal acid lipase deficiency that causes fat to accumulate in the liver, spleen and vasculature. A form of the disease that strikes infants is quickly fatal. A second form that affects older patients causes liver enlargement, fibrosis and cirrhosis, as well as cardiovascular disease.
Kanuma joins the growing group of ‘farmaceuticals' on the US market, which includes genetically modified goats that produce an anticoagulant called ATryn (antithrombin) in their milk, and transgenic rabbits producing a drug for treating hereditary angioedema. Unlike the genetically engineered AquAdvantage salmon that was approved by the FDA previously, the transgenic Kanuma producing-chickens are not intended to enter the food supply.
For more details, read the news article in Nature.
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Paris Climate Agreement Recognizes Food Security as a Priority
- Nobel Laureate: GM Crops Vital to Address Malnutrion
- Farmers in Western Kenya Request for Speedy Commercialization of GM Cotton
- Kenya National Biosafety Authority Receives Public Comments on Bt Cotton Environmental Release Application
- Zambia National Biosafety Authority Launched
- Scientists Sequence Walnut Genome
- Vietnam Sets New Rules on Labeling GM Foods
- China Shares Biotech Commercialization Experience with Developed Countries
- First Map of Wheat Epigenome Created
- Characterization of the Stress-inducible PLATZ Gene from Soybean
- JMJ704 Protein Regulates Rice Defense Response Against Xanthomonas oryzae pv. oryzae
- Expression of Silencing-Suppressor Protein Enhances the Performance of an Engineered Metabolic Pathway
Beyond Crop Biotech
- Enzyme-Producing GE Chicken Gets Approval in the US
- Genus and University of Missouri Develop Pigs Resistant to Incurable Disease
From the BICs
- IndoBIC Conducts Visit to Corn Research Stations in Malang, Indonesia
Read the latest:
- Crop Biotech Update (August 10, 2022)
- Genome Editing Supplement (August 10, 2022)
- Gene Drive Supplement (July 27, 2022)
Subscribe to CBU: